Lexeo Therapeutics, Inc. Common Stock (LXEO) vs Quantum-Si incorporated (QSI)
A side-by-side comparison of Lexeo Therapeutics, Inc. Common Stock and Quantum-Si incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LXEO
Lexeo Therapeutics, Inc. Common Stock
$3.32HealthcareDelayed quote: Oct 6, 2026, 1:15 PM EDT
QSI
Quantum-Si incorporated
$1.24HealthcareDelayed quote: Oct 6, 2026, 1:15 PM EDT
Total return — LXEO vs QSI
growth of $100 · dividends reinvested · last 3yLXEO -66.1% (-30.3%/yr)QSI -7.2% (-2.5%/yr)QSI compounded faster over this window
LXEO QSI
LXEO vs QSI: by the numbers
- •LXEO is the larger company ($261M vs $245M market cap).
- •Both run net losses; LXEO's is the smaller (0.00% vs -6138.26% net margin).
Metrics side by side
Valuation
| Metric | LXEO | QSI |
|---|---|---|
| P/S ratio | N/A | 152.88 |
| P/B ratio | 1.11 | 1.36 |
Profitability
| Metric | LXEO | QSI |
|---|---|---|
| Gross margin | 0.00% | 47.33% |
| Operating margin | 0.00% | -3996.72% |
| Net margin | 0.00% | -6138.26% |
| ROE | -37.12% | -54.67% |
| ROIC | -39.76% | -51.87% |
Growth (annualized)
| Metric | LXEO | QSI |
|---|---|---|
| Total return CAGR (5Y) | N/A | -31.06% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.